Log in

HBP Helix BioPharma Corp. TSX · Canada

Helix BioPharma (HBP) news HBP convertible notes news

Latest Helix BioPharma news

We have not published a story on Helix BioPharma yet. When there is news, it will appear here.

Questions about Helix BioPharma

Has Helix BioPharma sold convertible notes?

Our latest story on this, dated Jun 3, 2026: "Helix BioPharma closes C$3,673,000 convertible debenture placement". The story links the filing or release it is based on. Read the story.

What is the ticker symbol of Helix BioPharma?

Helix BioPharma Corp. trades under the ticker HBP on TSX.

Where is Helix BioPharma listed?

Helix BioPharma Corp. is listed on TSX.

Which country or territory is Helix BioPharma listed under?

Our directory records Helix BioPharma Corp. under Canada.

What does Helix BioPharma do?

Our directory classifies Helix BioPharma Corp. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Helix BioPharma?

The ISIN recorded for Helix BioPharma Corp. is CA4229102088.

Does aibio.space cover Helix BioPharma?

aibio.space lists Helix BioPharma Corp. among 2,820 public biotech companies and publishes its news here as stories appear.

What is the latest Helix BioPharma (HBP) stock news?

Our latest story on Helix BioPharma, dated Jun 3, 2026: "Helix BioPharma closes C$3,673,000 convertible debenture placement". The unsecured debentures carry 25.00% simple interest, mature 14 months after closing and can convert at C$1.42 per share. Source.

Which companies are similar to Helix BioPharma?

Companies in our directory listed in the same country and business area as Helix BioPharma: PharmAla Biotech Holdings, Resverlogix, Marvel Biosciences, RepliCel Life Sciences, LSL Pharma Group, Xenon Pharmaceuticals.

How can I follow Helix BioPharma (HBP) news?

Press Follow on this page to add Helix BioPharma to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming Helix BioPharma so far, in Debt Financing.

Investor discussion: Helix BioPharma

Members talk about Helix BioPharma (HBP). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TSX:HBP on TradingView.

Listing details

Helix BioPharma Corp. is a public biotech or pharmaceutical company listed on TSX under the ticker HBP, recorded under Canada. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Helix BioPharma Corp.
Ticker
HBP
Listing
TSX
Country or territory
Canada
Business scope
Pharmaceuticals: Major
ISIN
CA4229102088
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.